Rankings
▼
Calendar
MLYS Q3 2022 Earnings — Mineralys Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
MLYS
Mineralys Therapeutics, Inc.
$2B
Q3 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$-1.29
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$192,000
Balance Sheet
Total Assets
$122M
Total Liabilities
$166M
Stockholders' Equity
-$43M
Cash & Equivalents
$49M
← FY 2022
All Quarters
Q4 2022 →
